Skip to content

Advertisement

Open Access

Inflammasome and caspase-1 inhibition caused by Bcl-2 and Bcl-XL may influence cytokine responses of lipopolysaccharide-stimulated peripheral blood mononuclear cells from septic patients

Critical Care201216:410

https://doi.org/10.1186/cc11156

Published: 8 February 2012

Keywords

Public HealthLymphomaPolysaccharideMononuclear CellPeripheral Blood Mononuclear Cell

In recent issues of Critical Care, Wu and colleagues [1] and Giamarellos-Bourboulis and colleagues [2] observed that cytokine responses in different concentrations of lipo polysaccharide (LPS) (1 and 10 pg/μL, respectively) stimulated peripheral blood mononuclear cells (PBMCs) of septic patients and healthy controls. Wu and colleagues found that interleukin-1beta (IL-1β) production of PBMCs from patients with sepsis was significantly higher than that from controls, whereas Giamarellos-Bourboulis and colleagues found the opposite result. In light of previous research, we would like to offer some remarks.

LPS can lead to the activation of nuclear factor-kappa-B (NF-κB) and the subsequent generation of pro-IL-1β [3], which is readily processe d into IL-1β by inflammasome-activated caspase-1 [4]. NF-κB also induces B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-XL), both of which could suppress the activation of caspase-1 by inhibiting NLRP1 (pyrin-containing nonobese diabetic-like receptor 1) and thus suppress the cleavage of pro-IL-1β [5]. When PBMCs were stimulated with low concentrations of LPS, the expression of pro-IL-1β could be predominant and functions of inflammasomes and caspase-1 were still reserved and thus IL-1β production was increased. When PBMCs were stimulated with high concentrations of LPS, the expression of Bcl-XL/Bcl-2 could greatly increase and lead to significant inhibition of caspase-1 and thus the production of IL-1β was decreased, although the expression of pro-IL-1β may not have been influenced significantly [2]. That may be the reason why the results of the two sets of authors were conflicting.

Since Bcl-2/Bcl-XL could be differently produced according to various concentrations of LPS, inhibiting Bcl-2/Bcl-XL with reagents like ABT-737 in order to make sure that inflammasome and caspase-1 are not suppressed in vitro would be necessary when trying to use LPS stimulation to assess the status of PBMCs from patients with sepsis.

Abbreviations

Bcl-2: 

B-cell lymphoma 2

Bcl-XL

B-cell lymphoma-extra large

IL-1β: 

interleukin-1beta

LPS: 

lipopolysaccharide

NF-κB: 

nuclear factor-kappa-B

PBMC: 

peripheral blood mononuclear cell.

Declarations

Authors’ Affiliations

(1)
RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, Department of Critical Care Medicine and Respiratory Intensive Care Unit, Shanghai, China

References

  1. Wu HP, Shih CC, Lin CY, Hua CC , Chuang DY: Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors. Crit Care 2011, 15: R224. 10.1186/cc10464PubMed CentralView ArticlePubMedGoogle Scholar
  2. Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, Raftogiannis M, Antonopoulou A, Joosten LA, Pickkers P, Savva A, Georgitsi M, van der Meer JW, Netea MG: Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia. Crit Care 2011, 15: R27. 10.1186/cc9974PubMed CentralView ArticlePubMedGoogle Scholar
  3. Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008, 8: 776-787. 10.1038/nri2402PubMed CentralView ArticlePubMedGoogle Scholar
  4. Schroder K, Tschopp J: The inflammasomes. Cell 2010, 140: 821-832. 10.1016/j.cell.2010.01.040View ArticlePubMedGoogle Scholar
  5. Bruey JM, Bruey-Sedano N, L uciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, Reed JC: Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129: 45-56. 10.1016/j.cell.2007.01.045View ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2012

Advertisement